This inventor holds 20 USPTO granted patents and 13 published patent applications and 4 EPO patents. Top assignees: Alcon, Inc., Alcon Pharmaceuticals Ltd., Novartis Ag. Active years: 2009-2026.
Company Filing History:
17 out of 1,300 
1 out of 28 
1 out of 3,974 
Years Active: 2009-2026
Title: **Martin Gründig: Innovator in Ophthalmic Technology**
Introduction
Martin Gründig, an accomplished inventor based in Rangsdorf, Germany, has made significant contributions to the field of ophthalmology through his innovative inventions. With a remarkable portfolio of 11 patents, Gründig continues to push the boundaries of technology in vision care.
Latest Patents
Among his latest innovations are two notable patents focused on eye tracking and measurement systems. The first patent, titled "Eye tracking fixation monitoring systems and methods," outlines systems and methods for tracking eye movement during diagnostic procedures. This invention utilizes an eye tracker to capture images of the eye, alongside a control processor that detects eye position and orientation, determines fixation parameters, and analyzes the data to track eye movements accurately.
The second patent details an "Ophthalmic system for measuring an eye," which includes advanced measuring devices like an optical coherence tomography (OCT) device and an aberrometer. This system is engineered to generate a sophisticated ocular model based on the light reflected from the eye, allowing for precise evaluation of measurements collected from multiple devices.
Career Highlights
Gründig's career is highlighted by his role at Alcon, a leading company in eye care, where he has been able to innovate and develop groundbreaking technologies in ophthalmic measurement. His dedication to improving patient outcomes and enhancing diagnostic procedures has positioned him as a key figure in his field.
Collaborations
Throughout his career, Martin Gründig has worked alongside talented colleagues, including Sascha Birkner and Horia Grecu. Their collaborations have fostered an environment of creativity and technical advancement, further contributing to the success of their projects and innovations in the ophthalmic industry.
Conclusion
Martin Gründig's relentless pursuit of innovation sets a remarkable example in the realm of medical technology. With a focus on enhancing eye care through his patented inventions, he continues to make an indelible impact on diagnostic procedures and patient care within the ophthalmology sector.